XML 36 R27.htm IDEA: XBRL DOCUMENT
v3.23.1

Organization and Description of Business (Details) | Aug. 01, 2018 | Aug. 31, 2020
--- | --- | ---
Accounting Policies [Abstract] |  |
Description of acquired | On August 1, 2018, the Company acquired 4P Therapeutics LLC (“4P Therapeutics”) for $2,250,000, consisting of 250,000 shares of common stock, valued at $1,850,000, and $400,000, and a royalty of 6% on all revenue generated by the Company from the abuse deterrent intellectual property that had been developed by 4P Therapeutics payable to the former owner of 4P Therapeutics. The former owner of 4P Therapeutics has been a director of the Company since April 2018, when the Company entered into an agreement to acquire 4P Therapeutics. |
Acquired percentage |  | 100.00%

X
- Definition Acquired percentage. + References No definition available. + Details
Name: | ntrb_AcquiredPercentage
Namespace Prefix: | ntrb_
Data Type: | dtr:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Description of acquired. + References No definition available. + Details
Name: | ntrb_DescriptionOfAcquired
Namespace Prefix: | ntrb_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_AccountingPoliciesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration